Effect of secretory DKK3 on circulating CD56bright natural killer cells in patients with liver cancer

被引：0
|
作者：
Liu, Da-Hua [1 ]
Wen, Gui-Min [2 ]
Song, Chang-Liang [3 ]
Xia, Pu [1 ,4 ]
机构：
[1] Jinzhou Med Univ, Biol Anthropol Inst, Coll Basic Med Sci, Jinzhou, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Coll Nursing, Dept Community Nursing, Jinzhou, Liaoning, Peoples R China
[3] Ctr Hosp Handan, Dept Radiotherapy, Handan, Hebei, Peoples R China
[4] Jinzhou Med Univ, Biol Anthropol Inst, Jinzhou 121000, Liaoning, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2023年 / 38卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Liver cancer; DKK3; NK cells; differentiation; cytotoxicity; NK CELLS; METHYLATION; EXPRESSION; MECHANISM; ALPHA;
D O I：
10.1177/03936155231169796
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background Liver cancer seriously threatens human health. Natural killer (NK) cells are an important part of the innate immune system and have strong anti-tumor ability. Immunotherapy based on NK cells has become a hot topic in the treatment of liver cancer. Methods In this study, we checked the serum DKK3 (sDKK3) and circulating CD56(bright) NK cells using ELISA and flow cytometry, respectively, in the blood of liver cancer patients. The effect on recombinant human DKK3 (rhDKK3) on CD56(bright) NK cells was analyzed in vitro. Results We found low levels of sDKK3 in liver cancer patients and a negative correlation between sDKK3 and circulating CD56(bright) NK cells. In addition, we found that DKK3 induced the differentiation and improved the cytotoxicity of CD56(bright) NK cells for the first time. It could be used as an agonist for NK cell-based immunotherapy. Conclusions Improving the clinical efficacy of NK cells through DKK3 will become a new strategy for cancer immunotherapy.
引用
收藏
页码：99 / 104
页数：6
相关论文
共 50 条
  • [41] Invasive Surgery Impairs the Regulatory Function of Human CD56bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis
    Reinhardt, Renate
    Pohlmann, Stephanie
    Kleinertz, Holger
    Hepner-Schefczyk, Monika
    Paul, Andreas
    Flohe, Stefanie B.
    PLOS ONE, 2015, 10 (06):
  • [42] Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression
    Law, Becker M. P.
    Wilkinson, Ray
    Wang, Xiangju
    Kildey, Katrina
    Lindner, Mae
    Rist, Melissa J.
    Beagley, Kenneth
    Healy, Helen
    Kassianos, Andrew J.
    KIDNEY INTERNATIONAL, 2017, 92 (01) : 79 - 88
  • [43] The Role of Circulating CD16+CD56+Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment
    Cui, Feng
    Qu, Di
    Sun, Ruya
    Tao, Han
    Si, Junru
    Xu, Yuqing
    DISEASE MARKERS, 2019, 2019
  • [44] KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer
    Mukherjee, Neelam
    Ji, Niannian
    Tan, Xi
    Chen, Chun-Liang
    Noel, Onika D. V.
    Rodriguez-Padron, Maria
    Lin, Chun-Lin
    Alonzo, David G. G.
    Huang, Tim H. H.
    Svatek, Robert S. S.
    CANCER MEDICINE, 2023, 12 (07): : 8970 - 8980
  • [45] Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
    Ziblat, Andrea
    Nunez, Sol Y.
    Raffo Iraolagoitia, Ximena Lucia
    German Spallanzani, Raul
    Torres, Nicolas I.
    Sierra, Jessica M.
    Secchiari, Florencia
    Domaica, Carolina I.
    Fuertes, Mercedes B.
    Zwirner, Norberto W.
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [46] Enhanced Cytotoxic Function of Natural Killer and CD3+CD56+ Cells in Cord Blood after Culture
    Tomchuck, Suzanne L.
    Leung, Wing H.
    Dallas, Mari H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (01) : 39 - 49
  • [47] Expansion of natural killer cells in patients with head and neck cancer:: Detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells
    Melioli, G
    Semino, C
    Margarino, G
    Mereu, P
    Scala, M
    Cangemi, G
    Crocetti, E
    Machì, AM
    Ferlazzo, G
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (04): : 297 - 305
  • [48] Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease
    Jabir, Nasimudeen R.
    Firoz, Chelapram K.
    Ahmed, Farid
    Kamal, Mohammad A.
    Hindawi, Salwa
    Damanhouri, Ghazi A.
    Almehdar, Hussein A.
    Tabrez, Shams
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (05) : 526 - 535
  • [49] A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer
    Gascon-Ruiz, Marta
    Ramirez-Labrada, Ariel
    Lastra, Rodrigo
    Martinez-Lostao, Luis
    Pano-Pardo, J. Ramon
    Sesma, Andrea
    Zapata-Garcia, Maria
    Moratiel, Alba
    Quilez, Elisa
    Torres-Ramon, Irene
    Yubero, Alfonso
    Domingo, Maria Pilar
    Esteban, Patricia
    Galvez, Eva M.
    Pardo, Julian
    Isla, Dolores
    CANCERS, 2023, 15 (02)
  • [50] Suppression of CD56bright NK cells in breast cancer patients is associated with the PD-1 and TGF-βRII expression
    Arianfar, Elaheh
    Khandoozi, Seyed Reza
    Mohammadi, Saeed
    Memarian, Ali
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (03) : 841 - 851
12345